CA2614902A1 - Dosage et conditionnement de medicaments a liberation controlee - Google Patents

Dosage et conditionnement de medicaments a liberation controlee Download PDF

Info

Publication number
CA2614902A1
CA2614902A1 CA002614902A CA2614902A CA2614902A1 CA 2614902 A1 CA2614902 A1 CA 2614902A1 CA 002614902 A CA002614902 A CA 002614902A CA 2614902 A CA2614902 A CA 2614902A CA 2614902 A1 CA2614902 A1 CA 2614902A1
Authority
CA
Canada
Prior art keywords
combination
plus
diuretic
inhibitor
blocking agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002614902A
Other languages
English (en)
Inventor
Andrew L. Abrams
Anand V. Gumaste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microdose Therapeutx Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2614902A1 publication Critical patent/CA2614902A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
CA002614902A 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee Abandoned CA2614902A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
US60/294,786 2001-05-31
CA002448997A CA2448997A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002448997A Division CA2448997A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Publications (1)

Publication Number Publication Date
CA2614902A1 true CA2614902A1 (fr) 2002-12-05

Family

ID=23134944

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002614902A Abandoned CA2614902A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002614899A Abandoned CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002448997A Abandoned CA2448997A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002614899A Abandoned CA2614899A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee
CA002448997A Abandoned CA2448997A1 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Country Status (8)

Country Link
EP (1) EP1408907A4 (fr)
JP (1) JP2005514966A (fr)
AU (1) AU2002303840A1 (fr)
BR (1) BRPI0209720A2 (fr)
CA (3) CA2614902A1 (fr)
NZ (1) NZ529696A (fr)
WO (1) WO2002096347A2 (fr)
ZA (1) ZA200402466B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
EP2671508B1 (fr) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Système pharma-informatique
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
EP1933815A2 (fr) * 2005-10-14 2008-06-25 Microdose Technologies Inc. Conditionnement pharmaceutique d'une combinaison posologique orale
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
SG10201810784SA (en) 2009-04-28 2018-12-28 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
CN102665807A (zh) 2010-01-05 2012-09-12 微剂量治疗技术公司 吸入设备和方法
MX2012011693A (es) 2010-04-07 2013-02-15 Proteus Digital Health Inc Dispositivo ingerible miniatura.
WO2012071280A2 (fr) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Dispositif ingérable avec produit pharmaceutique
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (fr) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Produit ingérable pouvant être mâché et système de communication associé
KR20150038038A (ko) 2012-07-23 2015-04-08 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 부품을 포함하는 섭취 가능한 이벤트 마커를 제조하기 위한 기술
DK2910013T3 (en) 2012-10-18 2018-08-06 Proteus Digital Health Inc Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
WO2014144738A1 (fr) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Appareil, système et procédé de détection de métal
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN109843149B (zh) 2016-07-22 2020-07-07 普罗秋斯数字健康公司 可摄入事件标记的电磁感测和检测
KR102605670B1 (ko) 2016-10-26 2023-11-24 오츠카 세이야쿠 가부시키가이샤 섭취 가능한 이벤트 마커를 갖는 캡슐을 제조하는 방법
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Also Published As

Publication number Publication date
WO2002096347A3 (fr) 2003-03-27
NZ529696A (en) 2008-07-31
WO2002096347A2 (fr) 2002-12-05
JP2005514966A (ja) 2005-05-26
EP1408907A4 (fr) 2010-02-24
ZA200402466B (en) 2006-07-26
BRPI0209720A2 (pt) 2017-06-13
EP1408907A2 (fr) 2004-04-21
CA2614899A1 (fr) 2002-12-05
CA2448997A1 (fr) 2002-12-05
AU2002303840A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
CA2614899A1 (fr) Dosage et conditionnement de medicaments a liberation controlee
US20020142035A1 (en) Metering and packaging of controlled release medication
US20040156903A1 (en) Metering and packaging of controlled release medication
EP1482914B1 (fr) Dispositif de distribution de medicament implantable pour l'oeil
TW201603834A (zh) 層狀醫藥調配物
AU2025210799A1 (en) Subcutaneous Biodegradable Reservoir Device
HU206044B (en) Process for producing compositions with controlled release of dihydropyridine derivatives as active ingredient
Belgamwar et al. Pulsatile drug delivery system.
Venkatraman et al. An overview of controlled release systems
US12290605B2 (en) Method for producing a drug delivery system
CZ420997A3 (cs) Vrstevnatá tableta pro řízené uvolňování účinných látek
AU770828B2 (en) Metering and packaging of controlled release medication
WO2007047371A2 (fr) Conditionnement pharmaceutique d'une combinaison posologique orale
AU2004200545B9 (en) Metering and packaging of controlled release medication
KR20230079457A (ko) 약물 전달 시스템
Patel et al. Current status of technologies and devices for chronotherapeutic drug delivery systems
HK1130174A (en) Metering and packaging of controlled release medication
CA3087272C (fr) Systeme d'administration de medicament
Kothawade et al. Chronotherapy: A New Branch of Therapy

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead